-
1 month ago | 
jamanetwork.com | Neal Bhatia |James Del Rosso |Linda Gold
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials Key PointsQuestion What is the efficacy and safety of DFD-29, 40 mg, a low-dose oral minocycline hydrochloride formulation, in moderate to severe rosacea compared with doxycycline, 40 mg, and placebo?
-
2 months ago | 
hcplive.com | Mona Shahriari |James Del Rosso
In the latest episode of The Medical Sisterhood, host Mona Shahriari, MD, an assistant clinical professor of dermatology at the Yale University School of Medicine and the associate director of clinical trials at Central Connecticut Dermatology Research, spoke alongside James Q.
-
Jan 17, 2024 | 
jofskin.org | Ahmed Kadry |James Del Rosso |Christopher G. Bunick
Main Article Content Mahmoud Ghannoum Ahmed Gamal Ahmed Kadry James Del Rosso Christopher Bunick Linda Stein Gold Leon Kircik Julie Harper Keywords acne, combination treatment, C. acnes, susceptibility, resistance, clindamycin, benzoyl peroxide Abstract References 1. Jesitus J. Dermatol Times. https://www.dermatologytimes.com/view/dermatologists-contribute-overuse-antibiotics. 2. Crawford WW, et al. J Invest Dermatol. 1979;72(4):187-90. 3. Thiboutot D, Gollnick H, Bettoli V, et al. J Am Acad...
-
Nov 13, 2023 | 
jofskin.org | Christopher G. Bunick |Neal Bhatia |James Del Rosso |Zoe D. Draelos
Main Article Content Christopher Bunick Neal Bhatia James Del Rosso Zoe Draelos Lawrence Eichnfield Leon Kircik Mark Lebwohl Melinda Gooderham Lawrence Green Adelaide Hebert Ronald Vender Matthew Zirwas Eric Simpson Linda Stein Gold Melissa Seal Scott Snyder David Osborne Patrick Burnett Robert Higham David Chu David Berk Keywords roflumilast cream, roflumilast foam, psoriasis, seborrheic dermatitis, atopic dermatitis, local tolerability References 1. Eastman WJ, et al. Cutis 2014;94:46–53....
-
Nov 13, 2023 | 
jofskin.org | James Del Rosso |Thomas Dermatology |Ludwig Maximillian
James Del Rosso JDR Dermatology Research and Thomas Dermatology, Las Vegas, USA Gil Yosipovitch Miller School of Medicine, University of Miami, Miami, USA Sonja Ständer Center for Chronic Pruritus, University Hospital Münster, Münster, Germany Jonathan Silverberg The George Washington University School of Medicine and Health Sciences, Washington, DC, USA Andreas Wollenberg Ludwig Maximillian University, Munich, Germany and Augsburg University Hospital, Augsburg, Germany Peter A. Lio...
-
Nov 13, 2023 | 
jofskin.org | Todd E. Schlesinger |Mark Lebwohl |James Del Rosso |Vishal Patel
Main Article Content Keywords Tirbanibulin, Actinic Keratosis, Real World Evidence, Safety, Tolerability Abstract References 1. Schlesinger T et al. Skin. 2023;7(3):771-787. 2. Blauvelt A et al. N Engl J Med. 2021;384(6):512–20. Article Sidebar Article Details How to Cite Schlesinger, T., Lebwohl, M., Del Rosso, J., Patel, V. A., Kircik, L., Armstrong, A., Berman, B., Rigel, D., Narayanan, S., Koscielny, V., Kasujee, I., & Bhatia, N. (2023). Safety and Tolerability of Tirbanibulin 1%...
-
May 20, 2023 | 
jofskin.org | Todd E. Schlesinger |Leon Kircik |James Del Rosso |Darrell S. Rigel
Main Article Content Keywords actinic keratosis, topical treatment, tirbanibulin, patient-reported outcomes, clinician-reported outcomes Abstract Background: Patients' experiences regarding topical actinic keratosis (AK) treatments may optimize clinical outcomes. PROAK study aimed to evaluate patient- and clinician-reported outcomes among adult patients with AK on face or scalp who were prescribed tirbanibulin in real-world clinical practice in the United States. Methods: Key primary endpoint...
-
May 20, 2023 | 
jofskin.org | Emmy Graber |Hilary E. Baldwin |Andrew Alexis |James Del Rosso
Main Article Content Keywords Acne, Symptoms, Impact, Social Functioning, Emotional Functioning, Activities of Daily Living, ADL, PROs, Patient Reported Outcomes, PROSES, Sarecycline, RWE, Real World Evidence, Disease Burden, Expert Panel Questionnaire, EPQ Abstract Objective: Evaluate patient self-perceived AV symptoms and impact of AV on emotional/social functioning and ADL, among AV patients in community practices across the U.S. Methods: Single-arm, prospective cohort study (PROSES:...
-
May 20, 2023 | 
jofskin.org | Danny Zakria |April Armstrong |Brian Berman |James Del Rosso
Main Article Content Keywords actinic keratosis, actinic keratoses, AK, topical treatment, patient reported outcomes, skin cancer, pre-cancer, squamous cell carcinoma, SCC Abstract Background: Actinic keratosis (AK) is one of the most common dermatologic diagnoses. While there are several treatment options, many topical therapies have poor adherence due to duration of treatment and local skin reactions (LSRs). Objective: To review the available literature on the most commonly used...
-
Mar 13, 2023 | 
jofskin.org | James Del Rosso |Pearl Kwong |Iftikhar Hussain |Sébastien Barbarot
Main Article Content Keywords Lebrikizumab, Atopic Dermatitis References 1. Tsoi LC et al. J Invest Dermatol. 2019; 139:1480-9. 2. Ultsch M et al. J Mol Biol.
